Literature DB >> 19661714

Effects of Psilocybe argentipes on marble-burying behavior in mice.

Yoshihiro Matsushima1, Osamu Shirota, Ruri Kikura-Hanajiri, Yukihiro Goda, Fumio Eguchi.   

Abstract

Psilocybe argentipes is a hallucinogenic mushroom. The present study examined the effects of P. argentipes on marble-burying behavior, which is considered an animal model of obsessive-compulsive disorder. P. argentipes significantly inhibited marble-burying behavior without affecting locomotor activity as compared with the same dose of authentic psilocybin. These findings suggest that P. argentipes would be efficient in clinical obsessive-compulsive disorder therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661714     DOI: 10.1271/bbb.90095

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

Review 1.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

Review 2.  A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive-compulsive disorder: Mapping the way forward.

Authors:  Geoffrey de Brouwer; Arina Fick; Brian H Harvey; De Wet Wolmarans
Journal:  Cogn Affect Behav Neurosci       Date:  2019-02       Impact factor: 3.282

Review 3.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 4.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 5.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

6.  Genetic Survey of Psilocybe Natural Products.

Authors:  Sebastian Dörner; Kai Rogge; Janis Fricke; Tim Schäfer; Jacob M Wurlitzer; Markus Gressler; Duyen N K Pham; David R Manke; Andrew R Chadeayne; Dirk Hoffmeister
Journal:  Chembiochem       Date:  2022-06-09       Impact factor: 3.461

Review 7.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 8.  Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jaime E C Hallak
Journal:  Braz J Psychiatry       Date:  2016-03       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.